Aclaris Therapeutics
ACRS
ACRS
99 hedge funds and large institutions have $289M invested in Aclaris Therapeutics in 2018 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 43 increasing their positions, 20 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.28% less ownership
Funds ownership: 95.74% → 95.46% (-0.28%)
33% less capital invested
Capital invested by funds: $431M → $289M (-$142M)
Holders
99
Holding in Top 10
1
Calls
$123K
Puts
$7K
Top Buyers
| 1 | +$20.7M | |
| 2 | +$13.9M | |
| 3 | +$9.73M | |
| 4 |
BlackRock
New York
|
+$8.15M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$8.04M |
Top Sellers
| 1 | -$21M | |
| 2 | -$7.9M | |
| 3 | -$6.14M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$5.53M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.46M |